Oxford, AstraZeneca Begin Advanced Vaccine Trials

The University of Oxford and AstraZeneca Plc have begun recruiting more than 10,000 subjects for advanced human studies of one of the world's fastest-moving experimental Covid-19 vaccines.



Comment
Show comments Hide Comments


Related Articles